December 28, 2024 04:27 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India mourns as nation bids farewell to Manmohan Singh with full state honours | Narendra Modi-led Union Cabinet passes 'Condolence Resolution' on passing of ex-PM Manmohan Singh | Space will be allocated for Manmohan Singh's memorial, announces Centre | He was my friend, philosopher, and guide: Sonia Gandhi remembers Manmohan Singh in an emotional post | Vladimir Putin condoles Manmohan Singh's death, calls him 'outstanding statesman' | Congress writes to PM Modi seeking space for building a memorial to Manmohan Singh | Manmohan Singh will be remembered as a kind person, a learned economist, and a leader dedicated to reforms: PM Modi | Russian ambassador to India Denis Alipov grieves Manmohan Singh's demise | Mumbai terror attack shook Manmohan Singh badly, recalls former deputy NSA | I have lost a mentor and guide: Rahul Gandhi writes on Manmohan Singh's demise
COVID-19: MSN Laboratories initiates phase III clinical trial of Molnupiravir for India

COVID-19: MSN Laboratories initiates phase III clinical trial of Molnupiravir for India

May 25, 2021, at 10:38 pm

Kolkata: MSN Laboratories Pvt. Ltd. (MSN), the front-runner in introducing various drugs in the treatment of Covid-19 and its complications, post its launch of Posaone (Posacanazole) tab & IV in the treatment of black fungus, announced on Tuesday that MSN is initiating phase III clinical trial of Molnupiravir capsules for the treatment of Covid-19 in India.